Tumor cell resistance to DNA-damaging agents: From apoptosis to neiosis

Current Medicinal Chemistry - Anti-Cancer Agents

Volumn 4, Issue 5, 2004, Pages 461-463

  Martin, François ^a   Solary, Eric ^a  

^a INSERM   (France)

Author keywords

Apoptosis; Drug resistance; Mitotic catastrophe; Neiosis; Senescence

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CARRIER PROTEIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DNA TOPOISOMERASE; GLUTATHIONE; GLYCOPROTEIN P; PROTEIN BCL 2; PROTEIN P16; RAPAMYCIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER GENETICS; CANCER RESISTANCE; CELL AGING; CELL DIVISION; CYTOTOXICITY; DNA DAMAGE; DNA REPAIR; DRUG DETOXIFICATION; DRUG EFFICACY; DRUG PENETRATION; DRUG RESPONSE; DRUG SENSITIVITY; DRUG TARGETING; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; LEUKEMIA; MITOSIS; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR CELL;

ANIMALS; APOPTOSIS; CELL AGING; CELL DIVISION; DNA DAMAGE; DRUG RESISTANCE, NEOPLASM; HUMANS; MITOSIS; MODELS, BIOLOGICAL; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 4444375178     PISSN: 15680118     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568011043352768     Document Type: Article

References (19)

1. Marsh, S.; McLeod, H.L. Br. J. Cancer, 2004, 90, 8.
2. Chauffert, B.; Favoulet, P.; Polycarpe, E.; Duvillard, C.; Beltramo, JL.; Bichat, F.; Rat, P.; Genne, P.; Benoit, L. Surg. Oncol. Clin. N. Am., 2003, 12, 835.
3. Gottesman, M.M. Annu. Rev. Med., 2002, 53, 615.
4. Sordet, O.; Khan Q.A.; Kohn, K.W.; Pommier, Y.G. Curr. Med. Chem. Anti-Canc. Agents, 2003, 3, 271.
5. Johnstone, R.W.; Ruefli, A.A.; Lowe, S.W. Cell, 2002, 108, 153.
6. Roninson, I.B. Drug Resist. Updat., 2002, 5, 204.
7. Sundaram, M.; Guernsey, D.L.; Rajaraman, M.M.; Rajaraman, R. Cancer Biol. Ther., 2004, 3, 207.
8. Bettaieb, A.; Dubrez-Daloz, L.; Launay, S.; Plenchette, S.; Rebe, C.; Cathelin, S.; Solary, E. Curr. Med. Chem. Anti-Canc. Agents, 2003, 3, 307.
9. Fulda, S.; Fulda, S.; Debatin, K.M. Curr. Med. Chem. Anti-Canc. Agents, 2003, 3, 253.
10. Wendel, H.G.; De Stanchina, E.; Fridman, J.S.; Malina, A.; Ray, S.; Kogan, S.; Cordon-Cardo, C.; Pelletier, J.; Lowe, S.W. Nature, 2004, 428, 332.
11. Shay, J.W.; Roninson, I.B. Oncogene, 2004, 23, 2919.
12. te Poele, R.H.; Okorokov, A.L.; Jardine, L.; Cummings, J.; Joel, S.P. Cancer Res., 2002, 62, 1876.
13. Schmitt, C.A.; Fridman, J.S.; Yang, M.; Lee, S.; Baranov, E.; Hoffman, R.M.; Lowe, S.W. Cell, 2002, 109, 335.
14. Chang, B.D.; Swift, M.E. ; Shen, M. ; Fang, J. ; Broude, E.V. ; Roninson, I.B. Proc. Natl. Acad. Sci. USA, 2002, 99, 389.
15. Bunz, F.; Hwang, P.M.; Torrance, C.; Waldman, T.; Zhang, Y.; Dillehay, L.; Williams, J.; Lengauer, C.; Kinzler, K.W.; Vogelstein, B. J. Clin. Invest., 1999, 104, 263.
16. Castedo, M.; Perfettini, J.L.; Roumier, T.; Andreau, K.; Medema, R.; Kroemer, G. Oncogene, 2004, 23, 2825.
17. Castedo, M.; Perfettini, J.L.; Roumier, T.; Valent, A.; Raslova, H.; Yakushijin, K.; Horne, D.; Feunteun, J.; Lenoir, G.; Medema, R.; Vainchenker, W.; Kroemer, G. Oncogene, 2004, 23, 4362
18. Verschuren E.W.; Klefstrom, J.; Evan, G.I.; Jones, N. Cancer Cell, 2002, 2, 229.
19. Ivanov, A.; Cragg, MS.; Erenpreisa, J.; Emzinsh, D.; Lukman, H.; Illidge, TM. J. Cell Sci., 2003, 116, 4095.